(Q44681461)

English

A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

based on heuristic

inferred from title

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

object named as

Po-Chin Liang

2

0 references

object named as

Kai-Wen Huang

5

0 references

object named as

Chih-Hung Hsu

7

0 references

object named as

Yao-Ming Wu

3

0 references

object named as

Ann-Lii Cheng

9

0 references

author name string

Chun-Chieh Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Jason C Cheng

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Chiun Hsu

8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Zhong-Zhe Lin

10

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

28 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Liver International

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1413-1419

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Treatment of advanced hepatocellular carcinoma: intraarterial infusion chemotherapy combined with interferon

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombosis

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Twenty-four hour intra-arterial infusion of 5-fluorouracil, cisplatin, and leucovorin is more effective than 6-hour infusion for advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Commentary: Sorafenib use in patients with advanced hepatocellular carcinoma and underlying Child-Pugh B cirrhosis: evidence and controversy

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12207

21 January 2018

Identifiers

10.1111/LIV.12207

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

release_hxn32xarlngcfiq3uofqzvhjom

1 reference

https://api.fatcat.wiki/v0/release/hxn32xarlngcfiq3uofqzvhjom

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44681461&oldid=2031637151"